SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Martín Cowie, Miles Fisher
Topics & Concepts
MedicineHeart failure with preserved ejection fractionHeart failureAlbuminuriaEmpagliflozinDiabetes mellitusInternal medicineEjection fractionBlood pressureUric acidCardiologyEndocrinologyGlycationType 2 diabetesDiabetes Treatment and ManagementCardiovascular Function and Risk FactorsPancreatic function and diabetes